<DOC>
	<DOC>NCT02414789</DOC>
	<brief_summary>Test and evaluate a new diagnostic method (SRM-MS/MS: Selected Reaction Monitoring- Mass spectrometry) for Lyme Borreliosis on human skin biopsies. Patients included are those with the early skin manifestation (erythema migrans). This new proteomic method will be compared to the two existing method: culture of Borrelia and PCR detection of Borrelia (DNA detection of the bacteria).</brief_summary>
	<brief_title>Lyme Borreliosis and Early Cutaneous Diagnostic</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Erythema Chronicum Migrans</mesh_term>
	<mesh_term>Glossitis, Benign Migratory</mesh_term>
	<criteria>Erythema migrant as criteria EUCALB or atypical form associated to tick's sting Patient having signed a consent Patient affiliated to a social security scheme Prior treatment with antibiotics Erythema migrans on the face Bleeding disorders Anticoagulant treatment Inability to give clear information (subject in an emergency situation, understanding of the topic difficulty, ...)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>erythema migrans</keyword>
	<keyword>Lyme</keyword>
	<keyword>early diagnosis</keyword>
	<keyword>skin biomarkers</keyword>
	<keyword>proteomics diagnostic</keyword>
	<keyword>mass spectrometry</keyword>
</DOC>